Literature DB >> 28149622

Prevention of organ dysfunction in septic shock: still looking for an effective treatment.

Giovanni Landoni1, Alessandro Belletti2, Alessandro Putzu3, Alberto Zangrillo1.   

Abstract

Entities:  

Year:  2016        PMID: 28149622      PMCID: PMC5227217          DOI: 10.21037/jtd.2016.12.82

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.

Authors:  A Belletti; M L Castro; S Silvetti; T Greco; G Biondi-Zoccai; L Pasin; A Zangrillo; G Landoni
Journal:  Br J Anaesth       Date:  2015-11       Impact factor: 9.166

Review 2.  Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.

Authors:  Elizabeth K Stevenson; Amanda R Rubenstein; Gregory T Radin; Renda Soylemez Wiener; Allan J Walkey
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

Review 3.  Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.

Authors:  Dimitrios Farmakis; Julian Alvarez; Tuvia Ben Gal; Dulce Brito; Francesco Fedele; Candida Fonseca; Anthony C Gordon; Israel Gotsman; Elena Grossini; Fabio Guarracino; Veli-Pekka Harjola; Yaron Hellman; Leo Heunks; Visnja Ivancan; Apostolos Karavidas; Matti Kivikko; Vladimir Lomivorotov; Dan Longrois; Josep Masip; Marco Metra; Andrea Morelli; Maria Nikolaou; Zoltán Papp; Alexander Parkhomenko; Gerhard Poelzl; Piero Pollesello; Hanne Berg Ravn; Steffen Rex; Hynek Riha; Sven-Erik Ricksten; Robert H G Schwinger; Bojan Vrtovec; M Birhan Yilmaz; Marzenna Zielinska; John Parissis
Journal:  Int J Cardiol       Date:  2016-07-29       Impact factor: 4.164

4.  Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.

Authors:  Rajendra H Mehta; Sean Van Diepen; James Meza; Paula Bokesch; Jeffrey D Leimberger; Sandra Tourt-Uhlig; Merri Swartz; Jodi Parrotta; Rachael Jankowich; Douglas Hay; Robert W Harrison; Stephen Fremes; Shaun G Goodman; John Luber; Wolfgang Toller; Matthias Heringlake; Kevin J Anstrom; Jerrold H Levy; Robert A Harrington; John H Alexander
Journal:  Am Heart J       Date:  2016-09-09       Impact factor: 4.749

Review 5.  Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress.

Authors:  Martin W Dünser; Walter R Hasibeder
Journal:  J Intensive Care Med       Date:  2009-08-23       Impact factor: 3.510

6.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

Authors:  Carolin Fleischmann; André Scherag; Neill K J Adhikari; Christiane S Hartog; Thomas Tsaganos; Peter Schlattmann; Derek C Angus; Konrad Reinhart
Journal:  Am J Respir Crit Care Med       Date:  2016-02-01       Impact factor: 21.405

7.  Pragmatic Trials.

Authors:  Ian Ford; John Norrie
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

8.  Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).

Authors:  Thibaut Caruba; Delphine Hourton; Brigitte Sabatier; Dominique Rousseau; Annick Tibi; Cécile Hoffart-Jourdain; Akim Souag; Nelly Freitas; Mounia Yjjou; Carla Almeida; Nathalie Gomes; Pascaline Aucouturier; Juliette Djadi-Prat; Philippe Menasché; Gilles Chatellier; Bernard Cholley
Journal:  J Cardiothorac Surg       Date:  2016-08-05       Impact factor: 1.637

Review 9.  Critical care and the global burden of critical illness in adults.

Authors:  Neill K J Adhikari; Robert A Fowler; Satish Bhagwanjee; Gordon D Rubenfeld
Journal:  Lancet       Date:  2010-10-11       Impact factor: 79.321

Review 10.  Levosimendan: current data, clinical use and future development.

Authors:  M S Nieminen; S Fruhwald; L M A Heunks; P K Suominen; A C Gordon; M Kivikko; P Pollesello
Journal:  Heart Lung Vessel       Date:  2013
View more
  1 in total

1.  Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.

Authors:  Wei Chang; Jian-Feng Xie; Jing-Yuan Xu; Yi Yang
Journal:  BMJ Open       Date:  2018-03-30       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.